Novo Nordisk Warns of First Sales Drop Since Start of Ozempic

New York Times - Feb 4, 2026

The once high-flying Danish drugmaker has struggled to fend off rivals in the weight-loss industry, especially Eli Lilly, which gave a much rosier outlook to investors.

Read full article

More News

Deck Biz

Deck Biz is an intelligent platform providing international and regional business news updates. You won’t get these insights elsewhere other than Deck Biz.

Sign Up